Germany: Merck stops development of Parkinson's disease treatment

23.06.2006 04:30

Darmstadt-based Merck said it decided "not to file for approval and not to pursue further development of the compound," known as Sarizotan, which was intended to treat advanced Parkinson's disease patients suffering from dyskinesia, the AP reports.

The setback comes after Merck lost out to Bayer AG in the race to acquire a third German drug maker, Schering AG.

Subscribe to Pravda.Ru Telegram channel, Facebook, RSS!

Author`s name Editorial Team

Moment when Russian general is killed in bomb blast captured on video

The moment of the explosion that killed the head of Radiation, Chemical and Biological Defense Troops of the Armed Forces of Russia Igor Kirillov and his assistant was captured on video

Video shows moment when Russian general killed in Moscow

Moscow responds to Kyiv's reports on 30 dead North Korean fighters near Kursk

Moscow responds to reports about 30 dead North Korean fighters in Russia's Kursk region

Russia strikes Kyiv in response to ATACMS/Storm Shadow attack on Rostov

Keir Simmons grabs his backpack and leaves Putin's Q&A conference in a hurry